Objectives. This study determined the frequency of improvement in peak oxygen uptake and its role in reevaluation of candidates awaiting heart transplantation.
sudden death, for which the monthly risk is highest during the 1st 6 months that they are on the active transplant candidate list (2) . Those candidates who survive at home frequently demonstrate progressive improvement after redesign of their medical therapy (3, 4) .
The limited supply of donors and the restricted life span of the donor heart justify the strategy of postponing transplantation in patients who improve to become comfortable and functional, as long as their expected mortality rate does not significantly exceed that expected with transplantation. The traditional indications of listing for transplantation patients who have "end-stage" or "refractory" heart failure have recently been supplemented by more objective criteria including exercise peak oxygen uptake <14 ml/kg per min, shown by Mancini et al. (5) to identify those patients at highest risk without transplantation. However, peak oxygen uptake has been shown to improve with vasodilator and exercise therapy in patients with less severe heart failure (6) (7) (8) . When can an outpatient candidate who was initially listed for appropriate indications be considered for removal from the active candidate list?
This study addressed the hypotheses that 1) improvement in oxygen uptake could frequently be demonstrated in patients with initial oxygen consumption <14 ml/kg per min, and 2) serial measurement of peak oxygen uptake may be incorporated into a strategy to identify transplant candidates who can safely be removed from the active waiting list despite initial peak oxygen uptake <14 ml/kg per rain.
Methods

Study patients. Consecutive ambulatory patients under-
going formal evaluation for heart transplantation from 1988 through 1992 were chosen for this study if 1) they demonstrated a peak oxygen uptake <14 ml/kg per rain after achieving a respiratory quotient >1, and 2) they did not have major medical or psychosocial contraindications to heart transplantation (9) . Patients were excluded from this study if they had diseases other than dilated heart failure, such as hypertrophic and primary restrictive cardiomyopathy, for which natural history and some other considerations may vary.
Exercise testing. Patients underwent a warm-up period for 6 rain on the bicycle at a constant work load of 20 W. They were then allowed to rest for 5 to 15 min, until heart rate returned to baseline. Further rest was allowed if necessary until oxygen consumption returned to the initial baseline value. Incremental work load bicycling was then begun, with 2 to 3 rain of unloaded cycling followed by continuously increasing work load at 15 W/min. The respiratory exchange ratio was monitored and all patients were encouraged to exercise past a ratio = 1 to limiting symptoms. Breath by breath gas analysis was performed with the Medical Graphics 2000 metabolic cart. Oxygen uptake (Vo2), carbon dioxide release (Vcoz), ventilation, ventilatory equivalents for oxygen and carbon dioxide were measured continuously, using averages of 8 breaths. Blood pressure and heart rate were measured at 3-rain intervals and at peak exercise. Anaerobic threshold was estimated by the V-slope method and confirmed by ventilatory criteria.
All ambulatory patients without unstable angina or refractory ventricular arrhythmias underwent exercise testing at baseline. All candidates surviving without transplantation underwent repeat testing between 3 and 12 months after initial evaluation unless they had developed greater instability with respect to angina or hemodynamic decompensation. In the later years of the study, repeat testing was performed within 6 months of the initial test (48 of 68 retested patients).
Medical management. After initial screening on referral, all patients advancing to formal evaluation underwent right heart catheterization to determine pulmonary pressures, resistance and gradient as part of the determination of transplant eligibility. Patients with pulmonary capillary wedge pressure >20 mm Hg or cardiac index <2.2 liters/min per m 2 had the catheter left in place for adjustment of vasodilator and diuretic therapy (4) . Vasodilators and diuretic agents were tailored to approach hemodynamic goals of pulmonary capillary wedge pressure -<15 mm Hg and systemic vascular resistance -<1,200 dynes-s.cm -5 while maintaining systolic blood pressure at ->80 mm Hg as described for transplant candidates (4) . During the 1st 2 years of the study period, hemodynamic optimization was designed with either captopril or hydralazine in combination with oral nitrate therapy; after the results of the Hy-C trial in October 1990 (10) , all patients without contraindications to angiotensin-converting enzyme inhibitors were initially given a captopril-isosorbide dinitrate combination, with the addition or substitution of hydralazine or increased isosorbide dinitrate, or both, if necessary to achieve adequate vasodilation without unacceptable side effects. The diuretic regimen was based on loop diuretics and adjusted according to daily weight, with the intermittent addition of metolazone if necessary. Amiodarone was the preferred antiarrhythmic agent if therapy was thought to be indicated for atrial or ventricular arrhythmias. From June 1989 onward, amiodarone was recommended not only for symptomatic arrhythmias, but as part of a prospective trial in patients with heart failure who had high grade ventricular arrhythmias detected on ambulatory monitoring. Patients did not undergo formal rehabilitation or training but were instructed to walk without stopping at least 4 times weekly, outdoors or in covered shopping malls, starting at a time and distance comfortably achieved and increasing weekly to a target duration of 20 to 30 min or 2 miles. Patients were taught to check their heart rate and advised to achieve a level close to that observed at the onset of anaerobic metabolism as estimated from their baseline exercise test.
Candidacy for transplantation. In the absence of formally approved guidelines for transplant selection during the study period, evaluated patients with peak oxygen uptake < 14 ml/kg per min who were without major medical or psychosocial contraindications (9) were generally listed for heart transplantation. If awaiting further support system evaluation or compliance clearance (for smoking cessation, for example), patients for this study were considered to have been listed after initial evaluation. Patients in the last year of the study (18 patients) were informed at the time of listing that candidacy was a dynamic state that could change if their functional capacity improved or if noncardiac problems developed.
All listed transplant candidates were seen at intervals of 2 to 4 weeks by the center cardiologists, who evaluated them for No significant differences were observed between groups. Data are presented as number of patients or mean value ± SD. List = waiting list for heart transplantation; "vo 2 -oxygen uptake. clinical stability (Table 1) , as described previously (3). The strategy of reevaluation required that both the criterion of adequate exercise improvement and the preceding criteria for clinical stability had to be met before a patient could be removed from the active candidate list. Adequate exercise improvement was defined as an increase in peak oxygen uptake of >-2 ml/kg per min to a level >-12 ml/kg per min. All potential candidates continued to be followed up in the cardiomyopathy center whether or not they remained on the active list. Listing for transplantation, transplantation and death without transplantation were all analyzed as end points.
Statistical analysis. The three patient groups (1) without improvement, 2) with improvement and remaining on the transplant list, and 3) with improvement but removed from the list) were compared by using PROC GLM (SAS V.6.04). General comparisons were performed with analysis of variance, pairwise comparisons with Tukey's test. We also used contrasts to compare patients removed from the list versus others and patients with versus those without improvement. Changes within groups were assessed by paired t tests. Values were expressed as mean value +_ SD; p < 0.05 was considered significant. Actuarial survival was determined by Kaplan-Meier life-table analysis.
Results
Serial exercise performance. There were 107 ambulatory patients considered to be transplant candidates with peak oxygen uptake <14 ml/kg per rain (average 10 ml/kg per min). Of these, 39 did not undergo repeat testing because of either severe angina (n = 12), marked hemodynamic deterioration (n = 6), intervening transplantation (n = 15) or death (n = 6). The remaining 68 patients underwent repeat testing 6 +_ 5 months after initial evaluation.
Major improvement in exercise performance, defined as an increase in peak oxygen uptake >-2 ml/kg per min to a level >-12 ml/kg per rain, occurred in 38 of the 68 patients. Demo-graphic and hemodynamic profiles at baseline and frequency of coronary artery disease were not significantly different between the groups with and without improvement ( Table 2 ). However, the baseline exercise performance of the patients with subsequent improvement was characterized by higher peak heart rate, exercise heart rate reserve, work load, and initial anaerobic threshold ( Table 3) .
Therapy at discharge from initial evaluation was similar for patients with and without improvement ( Table 4 ). The majority were able to tolerate angiotensin-converting enzyme inhibitors without severe hypotension (systolic blood pressure <80 mm Hg) or worsening renal function. Amiodarone was added in a similar proportion of patients in both groups. Improvement in peak oxygen consumption was accompanied by an improvement in anaerobic threshold and work load. Patients whose improvement allowed their removal from the transplant list demonstrated increased exercise heart rate reserve, increased peak systolic blood pressure (without change in blood pressure at rest) and increased oxygen pulse ( Table 5 ). In these patients the increased heart rate reserve at reevaluation reflected a lower rest heart rate than that at initial evaluation (71 vs. 83 beats/min, p < 0.05).
Clinical reevaluation of listed outpatient candidates. Of the 38 patients with exercise improvement, 31 met the criteria for clinical stability. Among the other seven patients, four had continued recurrent episodes of fluid retention requiring intravenous diuretic drug therapy (although not on the day of the repeat exercise), two had improved exercise capacity to <13 ml/kg per rain and continued to be severely limited in routine activities and one patient had frequent angina.
The seven patients with improved exercise performance but without sutficient clinical stability to allow removal from the transplant list formed too small a group for meaningful comparisons. During their initial exercise test, peak heart rate, heart rate reserve and peak work load were similar to those patients whose exercise capacity did not subsequently improve ( Table 3 ). The increased peak oxygen consumption in these seven patients without clinical stability resulted from an increased peak exercise heart rate without a major increase in oxygen pulse ( Table 5 ).
The 31 patients manifesting clinical stability were advised, as were their families, that their condition had improved such that transplantation was not expected to yield major improvement in exercise capacity or survival during the following year. They were informed that their condition might deteriorate or that other complications precluding transplantation might develop. The risk of sudden death during the next year was Data are presented as number of patients or mean value + SD. ?Significant difference between patients without improvement and patients with major improvement. :~Significant difference between patients with improvement who were removed from the list and all others. All data are presented as mean value +_ SD. HR = heart rate; SBP = systolic blood pressure; other abbreviations as in Table 3. described to them as 15% to 25% (based on multicenter experience [11] and the earlier experience of this institution [12] , although the recent incidence has been lower [10] ). They were told that this risk was slightly but not substantially higher than the risks of fatal rejection, infection and other complications during the 1st year after transplantation. Subsequent reevaluation was planned to take place at 3-month intervals or in the event of clinical deterioration; if the latter had occurred they would rejoin the active waiting list with the previously accrued waiting time. These 31 patients, who had a mixed emotional response to this information, were then taken off the active transplant candidate list.
Survival and transplantation. Of the 30 patients without major improvement in exercise capacity, 5 are currently alive awaiting transplantation (Fig. 1) . The seven patients who had improved exercise capacity but remained on the active transplant candidate list have undergone transplantation. Of the 31 patients removed from the active list, 25 are currently alive without listing for transplantation and 5 have been relisted; 1 of the 5 required hospitalization until transplantation; 1 underwent transplantation as an outpatient; 1, who was relisted because of increasing angina, has been on the list for >2 years; and 2 have just been relisted at 13 and 30 months, respectively, after removal from the list. Death from respiratory failure Figure 1 . Flowchart depicting the outcome of ambulatory transplant candidates with initial peak oxygen consumption (pkVO:) <14 ml/kg per rain. The patient who died of respiratory failure at 25 months because of recurrent pneumothoraces is described in Results. CHF = congestive heart failure death.
patients with initial pkV02 <14
39 not retested due to 15 occurred at 25 months in one patient who developed recurrent pneumothoraces, then severe restriction after sclerosing therapy, but did not develop any signs of recurrent congestion before death. The 28 outpatients without transplantation are currently 21 + 10 months from the second exercise test. Even if the two patients who underwent transplantation were counted as having died instead of as having undergone transplantation, the actuarial survival rate for candidates removed from the active list according to the preceding criteria was 97% at 1 year and 92% at 2 years (Fig. 2) . The actuarial survival rate at 2 years without relisting for transplantation was 85%.
Discussion
This study demonstrates that peak oxygen uptake frequently improves while ambulatory candidates await heart transplantation. Most patients who demonstrate major improvement also meet criteria for clinical stability, particularly if baseline heart rate has decreased and peak oxygen pulse has increased. A strategy of candidate reevaluation that included repeat exercise testing identified a patient group with a shortterm survival rate equivalent to that of patients after heart transplantation, despite initial peak oxygen uptake <14 ml/kg per min (average 11 ml/kg per min). Improvement in exercise capacity. Multiple interventions have been shown to improve exercise capacity in patients with heart failure. The majority of the improvement has been reported to occur during long-term therapy (13) . Prolonged improvement of nutritive flow may be required to allow recovery of impaired skeletal muscle metabolism (14) (15) (16) . Nitrate therapy, the hydralazine-nitrate combination and angiotensin-converting enzyme inhibitors have all been shown to improve long-term exercise capacity in patients with heart failure (6, 7) . The effect of amiodarone on exercise capacity has not been assessed in these patients. In addition, formal exercise training can improve peak oxygen consumption, with a 20% increase described by Coats et al. (8) in patients with less severe heart failure. Although the patients in the current study did not undergo formal exercise programs, they were encouraged to begin a progressive program of regular walking, which had frequently been specifically proscribed before referral.
The patients in this study who showed improved exercise capacity had an average increase of 5 ml/kg per rain in peak oxygen uptake. Although multiple baseline tests could not be performed in this group, the improvement most likely reflects improved aerobic capacity, as there was >2 ml/kg per rain improvement also in the anaerobic threshold, which is less influenced than peak oxygen consumption by patient familiarity and effort. Lack of increase in the peak respiratory quotient on repeat testing makes it unlikely that patients were exercising to greater perceived intensity during the second test.
The increased functional reserve in patients with major improvement in both exercise and clinical status was associated with increased heart rate reserve during exercise, primarily due to a decreased heart rate at rest. The decreased heart rate may reflect increased vagal tone and decreased sympathetic tone at rest, which has been demonstrated after formal exercise training (8). The improved peak oxygen uptake was a product of both increased heart rate reserve and increased peak oxygen pulse, which reflects stroke volume and peripheral muscle utilization of oxygen. The increased peak systolic blood pressure may indicate a higher peak cardiac output or more efficient vasoconstriction of nonexercising vascular beds. In the seven patients who did not achieve clinical stability despite an improved peak oxygen uptake, peak heart rate increased without increased peak oxygen pulse or decrease in heart rate at rest.
Prediction of improvement. The baseline clinical and hemodynamic profile of patients evaluated did not reveal any criteria for initial identification of those patients who had subsequent improvement. On initial exercise testing, peak work load and anaerobic threshold were higher in patients with later improvement, although there was considerable overlap. The initial peak heart rate and exercise heart rate reserve were higher in the group with subsequently improved exercise tolerance, but only in those who also had sufficient accompanying clinical stabilization to leave the waiting fist. The initial parasympathetic/sympathetic balance may have been less abnormal in this group. Hemodynamic data at the time of referral did not predict outcome, as previously shown (17) for such severely compromised patients, whose initial filling pressure and cardiac output may reflect primarily the intensity of prior treatment. Patients with and without coronary artery disease as their primary diagnosis demonstrated a similar chance of improvement. Previous history of heavy alcohol consumption, which could cause reversible myocardial depression, was not commonly documented.
Exercise capacity and eligibility for heart transplantation. The goal of the selection process is identification of those who will derive the greatest benefit from transplantation, in terms of both quality of life and survival (9) . Classical indications of "severe" or "end-stage" heart failure do not define the difference between the candidate who can achieve clinical stability despite a low ejection fraction and the candidate who is plagued by persistent congestive symptoms despite optimal therapy. Measurement of oxygen uptake and estimated anaerobic threshold allow more precise quantification of functional impairment in patients with heart failure (18) , whose varying degrees of effort and tolerance for anaerobic metabolism limit the value of measuring peak work load or duration. Measurement of peak oxygen uptake allows comparison of functional capacity in a patient with heart failure with that achieved by the average heart transplant recipient, both of which can be improved with training (8, 19) . The patients in this study with improved exercise capacity had an average peak uptake of 16 ml/kg per min on their repeat test, which is comparable to that achieved on the same testing protocol in the same institution 1 year after heart transplantation (3) although lower than that in some other studies (19) .
Mancini et al. (5) showed that measurement of peak oxygen uptake provides information about survival as well as functional capacity. Transplant candidates with a peak oxygen uptake <14 ml/kg per rain had a 32% survival rate at 2 years without transplantation compared to the 84% rate of those with higher oxygen uptake, a result that has introduced a new objectivity into candidate selection. It should be noted that exercise in the current study was performed with a bicycle, on which normal subjects achieve a peak oxygen uptake 5% to 10% lower than that achieved on a treadmill, which uses more muscle groups but may be less easy to standardize in compromised patients (20) .
Because peak oxygen consumption can improve with medical therapy and regular exercise itself, the value of the test for assessing both functional capacity and survival may increase when it is repeated after enhanced medical therapy and activity. The capacity to improve oxygen consumption may itself be a favorable prognostic sign, indicative of a permissive milieu of improved perfusion and activity reflecting a return toward more normal circulatory integration. This may be particularly true in the presence of a reduction in heart rate at rest, consistent with increased parasympathetic tone, which has been associated with more favorable prognosis (21) .
Reevaluation of cardiac transplant candidates. There are currently >2,800 candidates awaiting heart transplantation in the United States with >300 added each month. Thus, some 6,400 patients will be on the list for some part of this year, during which -2,100 donor hearts will become available (1). The highest interval risk for these patients is during the first few months after evaluation. Candidates surviving this period may show improvement, as a result of both more intensive medical therapy and resolution of unrecognized exacerbating factors. The prolonged waiting times are actually selecting a group of patients with better survival rates than those of the group initially listed (2) . After the ardors of selection and the ceremony of awarding the beeper, it may be difficult to convince a patient and his referring physician that his very survival may be an indication for removal from the list. Candidates who have responded well to medical therapy frequently ask, "Do I still need a transplant?", but they and their physicians fear loss of candidacy. Identification of a candidate who can defer or avoid transplantation thus requires definitive criteria.
Among the 107 potential candidates with initial peak oxygen uptake <14 ml/kg per min, the 24 patients who did not undergo repeat testing because of severe angina, clinical deterioration or death were clearly candidates who could have benefited from transplantation. Some of the 15 outpatients who underwent elective transplantation before undergoing a second test may have demonstrated sufficient improvement to postpone transplantation, but this cannot be known. For the 29% of all the ambulatory patients listed with low peak oxygen uptake who were judged to have sufficient improvement to leave the active list, the survival of 85% without relisting at an average of 21 months compares well with the 2-year posttransplant survival rate of 75% in the international registry (22) .
The longer-term prognosis for patients with severe heart failure remains very limited. Even in patients with milder heart failure in the VHEFT study and symptomatic arm of the SOLVD trial, the 4-year survival rate was 50%-60% (23, 24) . The 5-year survival rate after heart transplantation is >70% in major centers. The life span of a transplanted heart is limited, however, by accelerated coronary vasculopathy, which affects >50% of recipients by 5 years and is a major cause of late mortality (25) . The total life expectancy is maximized by waiting as long as possible before transplantation, as long as functional capacity and 1-year prognosis remain similar to those expected from transplantation. The quality of life is clearly maximized also by reducing time spent waiting for transplantation, a state characterized by unique anxiety and family stresses. Rather than looking at 5-year survival from the outset, it may be more appropriate to consider only 1 year at a time when timing transplantation.
The major obstacle to rational listing and reevaluation of potential transplant candidates is a lack of consensus among programs. The long waiting times stimulate earlier listing of patients to "build up time on the list," whereas newly listed outpatients with greater immediate need may die for lack of a heart. Like disarmament, a policy leading to more effective use of limited resources requires simultaneous cooperation to a greater degree than has been evident among transplant centers (26) .
Limitations, As the routine study of these compromised patients did not include repeat baseline exercise, improved oxygen uptake may have resulted partly from familiarity with the testing apparatus. The use of a 6 rain warm up period, lack of improvement in many patients and concordance of increased anaerobic threshold suggest that improved oxygen uptake reflected true improvement in aerobic capacity. Other indexes of improvement, such as precise ejection fraction, may also be helpful (27) .
The results of this study can be applied only to ambulatory patients able to undergo exercise testing. Inability to perform bicycle exercise may indicate greater risk. Low peak oxygen consumption must be considered in relation to predicted values and individual patient trends as only one of several indications for transplantation, which include refractory arrhythmias or severe uncorrectable myocardial ischemia (26) .
Implications. This study represents a first step toward the establishment of guidelines for reevaluation of heart transplant candidates. The lack of information at listing that predicts later improvement strengthens the concept that transplant candidacy is a dynamic state. As waiting lists lengthen further, systematic reevaluation may increase overall survival, both by lengthening the time of quality life before transplantation and by distributing the donor hearts expeditiously to those candidates who are least likely to survive without them.
